Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1968 2
1970 1
1976 1
1977 2
1978 1
1981 1
1982 4
1983 2
1984 4
1985 2
1986 6
1987 2
1988 10
1989 11
1990 6
1991 8
1992 6
1993 9
1994 7
1995 10
1996 9
1997 10
1998 4
1999 13
2000 15
2001 13
2002 18
2003 18
2004 19
2005 10
2006 20
2007 30
2008 15
2009 11
2010 21
2011 21
2012 20
2013 25
2014 27
2015 37
2016 38
2017 40
2018 33
2019 45
2020 47
2021 52
2022 64
2023 67
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

790 results

Results by year

Filters applied: . Clear all
Page 1
Structural basis for ion selectivity in potassium-selective channelrhodopsins.
Tajima S, Kim YS, Fukuda M, Jo Y, Wang PY, Paggi JM, Inoue M, Byrne EFX, Kishi KE, Nakamura S, Ramakrishnan C, Takaramoto S, Nagata T, Konno M, Sugiura M, Katayama K, Matsui TE, Yamashita K, Kim S, Ikeda H, Kim J, Kandori H, Dror RO, Inoue K, Deisseroth K, Kato HE. Tajima S, et al. Cell. 2023 Sep 28;186(20):4325-4344.e26. doi: 10.1016/j.cell.2023.08.009. Epub 2023 Aug 30. Cell. 2023. PMID: 37652010 Free PMC article.
KCR channelrhodopsins (K(+)-selective light-gated ion channels) have received attention as potential inhibitory optogenetic tools but more broadly pose a fundamental mystery regarding how their K(+) selectivity is achieved. ...Thus, discovery of a mechanism for ion- …
KCR channelrhodopsins (K(+)-selective light-gated ion channels) have received attention as potential inhibitory optogenetic tools but …
Fatty acid overproduction by gut commensal microbiota exacerbates obesity.
Takeuchi T, Kameyama K, Miyauchi E, Nakanishi Y, Kanaya T, Fujii T, Kato T, Sasaki T, Tachibana N, Negishi H, Matsui M, Ohno H. Takeuchi T, et al. Cell Metab. 2023 Feb 7;35(2):361-375.e9. doi: 10.1016/j.cmet.2022.12.013. Epub 2023 Jan 17. Cell Metab. 2023. PMID: 36652945 Free article.
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Yasuda S, et al. N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2. N Engl J Med. 2019. PMID: 31475793 Clinical Trial.
METHODS: In a multicenter, open-label trial conducted in Japan, we randomly assigned 2236 patients with atrial fibrillation who had undergone percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) more than 1 year earlier or who had angiographically co …
METHODS: In a multicenter, open-label trial conducted in Japan, we randomly assigned 2236 patients with atrial fibrillation who had undergon …
Drug-nutrient interaction.
Matsui MS, Rozovski SJ. Matsui MS, et al. Clin Ther. 1982;4(6):423-40. Clin Ther. 1982. PMID: 7046936 Review.
Cholestyramine therapy has been associated with malabsorption of vitamins; several reports suggest that cholestyramine affects absorption of the fat-soluble vitamins K and D and, in addition, may alter water-soluble vitamins, including folic acid. ...
Cholestyramine therapy has been associated with malabsorption of vitamins; several reports suggest that cholestyramine affects absorption of …
Differential Expression of Na/K-ATPase in the Human Saccule of Patients With and Without Otologic Disease.
Avillion MP, Lopez IA, Matsui H, Ishiyama G, Ishiyama A. Avillion MP, et al. Otol Neurotol. 2023 Apr 1;44(4):e256-e261. doi: 10.1097/MAO.0000000000003834. Epub 2023 Feb 15. Otol Neurotol. 2023. PMID: 36791368 Free PMC article.
HYPOTHESIS: Na + , K + -ATPase (Na/K-ATPase) alpha1 subunit expression in the saccule of patients diagnosed with otologic disease is different compared with normal controls. BACKGROUND: We have recently characterized changes in the expression of Na/K-ATPase a …
HYPOTHESIS: Na + , K + -ATPase (Na/K-ATPase) alpha1 subunit expression in the saccule of patients diagnosed with otologic dise …
Pepsinogen I- and H+/K+-ATPase-immunohistochemical Positivity in Endoscopically Resected Early Gastric Neoplasia.
Hayasaka J, Inoshita N, Suzuki Y, Nomura K, Odagiri H, Ochiai Y, Tanaka M, Yamashita S, Matsui A, Kikuchi D, Kitagawa M, Hoteya S. Hayasaka J, et al. Am J Surg Pathol. 2022 Apr 1;46(4):443-453. doi: 10.1097/PAS.0000000000001861. Am J Surg Pathol. 2022. PMID: 34999591
The frequency of pepsinogen I-positive lesions was 2.1%, and that of H+/K+-ATPase-positive lesions was 2.0%. Pepsinogen I- or H+/K+-ATPase positivity was not observed in undifferentiated-type tumors, while gastric tumors with morphologic similarity to fundic glands …
The frequency of pepsinogen I-positive lesions was 2.1%, and that of H+/K+-ATPase-positive lesions was 2.0%. Pepsinogen I- or H+/K …
A case of eel collagen allergy.
Tamura M, Matsui K, Kobayashi Y, Ogita C, Tsuboi K, Kusakabe M, Azuma K, Abe T, Yoshikawa T, Sekiguchi M, Azuma N, Kitano M, Sano H. Tamura M, et al. Allergol Int. 2018 Jan;67(1):138-140. doi: 10.1016/j.alit.2017.04.012. Epub 2017 Jun 2. Allergol Int. 2018. PMID: 28583315 Free article. No abstract available.
K(Ca)3.1 inhibition-induced activation of the JNK/c-Jun signaling pathway enhances IL-10 expression in peripherally-induced regulatory T cells.
Matsui M, Kajikuri J, Endo K, Kito H, Ohya S. Matsui M, et al. J Pharmacol Sci. 2022 Jan;148(1):1-5. doi: 10.1016/j.jphs.2021.09.007. Epub 2021 Oct 1. J Pharmacol Sci. 2022. PMID: 34924112 Free article.
The K(Ca)3.1 inhibition up-regulates IL-10 expression in regulatory T (T(reg)) cells in the recovery phase of inflammatory bowel disease (IBD) model mice; however, the underlying signaling pathway remains unclear. ...The inhibition of K(Ca)3.1 increased phosphorylat …
The K(Ca)3.1 inhibition up-regulates IL-10 expression in regulatory T (T(reg)) cells in the recovery phase of inflammatory bowel dise …
Pathological Roles of Iron in Cardiovascular Disease.
Kobayashi M, Suhara T, Baba Y, Kawasaki NK, Higa JK, Matsui T. Kobayashi M, et al. Curr Drug Targets. 2018;19(9):1068-1076. doi: 10.2174/1389450119666180605112235. Curr Drug Targets. 2018. PMID: 29874997 Free PMC article. Review.
790 results